NL-OMON54782招募中4 期
Prevention of neuropsychiatric adverse effects caused by dexamethasone: insights from a placebo-controlled trial with hydrocortisone. - DEXA-CORT
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Cranial glioma, meningioma or brain metastasis scheduled to undergo surgery
- •(resection)
- •- Minimal dose of peri-operative cumulative dexamethasone of 24mg or more in 6
- •- >=18 years
- •- Good clinical condition; KPS>=70
- •- Life expectancy >=6 months
排除标准
- •- Non-native speakers of Dutch or insufficient command of the Dutch language
- •- Patients that are unable to overview consequences of trial participation
- •- Patients with severe aphasia
- •- Patients that are not able to fill in the questionnaires because of cognitive
- •impairments at the discretion of the physician
- •- Patients with psychiatric diseases or neurological deficits that interfere
- •with the study to the judgement of treating physician
研究者
相似试验
进行中（未招募）
1 期
Hydrocortisone as co-treatment to prevent neuropsychiatric adverse effects of dexamethasone.europsychiatric adverse effects which can be caused by dexamethasone. For example delirium, anxiety, depression, mania and psychosis. But also cognitive impairment and sleep disturbance.EUCTR2017-003705-17-NLMC180
已完成
不适用
Schizophrenia Termination Of Pharmacotherapy: STOP-trialSchizophrenia, schizophreniform disorder, schizoaffective disorderMental and Behavioural DisordersSchizophreniaISRCTN06332944The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)20
暂停
不适用
Schizophrenia Termination Of Pharmacotherapy-STOP-trial.Schizophrenic disorders:SchizophreniaSchizophreniform disorderSchizoaffective disorderNL-OMON26866Divisie Hersenen20
招募中
不适用
Indicated prevention of mental disorders in subjects with initial panic symptomatology: effectiveness and underlying mechanisms of actioF00-F99Mental and behavioural disordersDRKS00018077Technische Universität Dresden, Institut für Klinische Psychologie und Psychotherapie, Professur Behaviorale Epidemiologie300
已完成
不适用
Primary prevention of psychosis through interventions in the prodromal phaseISRCTN20328848Stavanger University Hospital (Norway)240